Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 31

Trial Status

Completed3

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT01735006Phase 3Completed
Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine
Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
StudydirectorStart date: 2012-11-22
NCT01356823Phase 2Completed
Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
Cervical CancerCervical Intraepithelial Neoplasia
Studydirector

Research Network

Collaboration Network

15 collaborators·17 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jun Zhang, master

Xiamen University

Very Similar
12 trials

Shared therapeutic areas:

Condylomata AcuminataCancer of the Uterine CervixUterine Cervical Dysplasia+3 more

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Jun Zhang+3 more
Collaborated on 3 trials
Similarity Score72%

Yuemei Hu, Bachelor

Jiangsu Provincial Centre for Disease Control and Prevention

Similar
3 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical DysplasiaPersistent Infection+2 more

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Jun Zhang+2 more
Collaborated on 1 trial
Similarity Score54%

Youlin Qiao, Ph.D

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Similar
1 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical DysplasiaPersistent Infection+2 more

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Ministry of Science and Technology of the People´s Republic of China+2 more
Collaborated on 1 trial
Similarity Score54%

Zhao-Jun Mo, Master

Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control

Related
1 trials

Shared therapeutic areas:

Condylomata Acuminata

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Jun Zhang+1 more
Collaborated on 1 trial
Similarity Score14%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical Dysplasia
Similarity Score10%

Juntao Ran

LanZhou University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score5%

Xiaojie Ma

Affiliated Hospital of North Sichuan Medical College

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score5%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score5%

Xiaoying Xue

The Second Hospital of Hebei Medical University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score5%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02405520Phase 1StudyDirector

Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Condylomata Acuminata
Completed
NCT01735006Phase 3StudyDirector

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine

Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
Completed
NCT01356823Phase 2StudyDirector

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Cervical CancerCervical Intraepithelial Neoplasia
Completed

All 3 trials loaded